Manhattan Pharmaceuticals Email Format

Pharmaceutical ManufacturingNew York, United States2-10 Employees

Manhattan Pharmaceuticals, Inc. is a specialty healthcare product company focused on developing and commercializing innovative treatments for underserved patient populations.  The current portfolio of product candidates includes:

    * AST-726 – a nasally delivered  form of hydroxocobalamin for the treatment of vitamin B 12 deficiency
    * Hedrin® – a novel, non-pesticide treatment for pediculosis (head lice)
    * AST-915 – an oral treatment for essential tremor
    * GEL – a topical gel for the treatment of mild psoriasis

Manhattan Pharmaceuticals is located in New York City and is traded on the OTC Bulletin Board® under the ticker symbol “MHAN”.

Sign up for free to view info

Company overview Employee directory